Search

NEWS

请拖入内容到容器

ABOUT US

Hangzhou Repugene Technology Co., Ltd. is a world class, industry leading, multi platform company lead by a diverse team of overseas returnees. 

Our platform includes independent research and development that emcompasses precise areas such as clinical oncology diagnosis, efficient identification and

drug resistance analysis of pathogenic microorganisms, comprehensive genome screening, general health care data management. Repugene will continue to

apply leading healthcare technology to clinical research and the pursuit of superior efficacious therapies and diagnostic methods, providing healthy and

patient populations with precise medical services.

Technology

Honor

Culture

Profile

请拖入内容到容器

PRODUCT SERVICE

Ripple has the world's leading gene big data analysis platform and a world-class bioinformatics analysis team, and has mastered advanced information analysis technology.

请拖入内容到容器

NEWS

Rip Gene's exciting information activities and real-time industry dynamics are at your fingertips

Dry goods|What you want to know about "single cell sequencing technology and applications" are here!

Dry goods|What you want to know about "single cell sequencing technology and applications" are here!

Each cell is unique, but most of the current research is directed at cell populations (such as whole tissue), ignoring the heterogeneity between cells. Single-cell sequencing is a new technology for simultaneous high-throughput sequencing of genomic, transcriptome, and epigenetic groups at the single cell level for up to tens of thousands of cells. Single-cell sequencing can more accurately analyze the difference between cells and cells, and realize the genetic detection from the "average value" to the "individual value", which is called the technology of gene sequencing 2.0 era. After the analysis, from the "individual value" to the "group value", it is possible to classify similar cell populations, count each type of cells and analyze their proportion and status in the population, which is a powerful clinical study and The platform for basic research.
Dry goods|What you want to know about
Happy news! Accurate and standard counterparts, Ripple

Happy news! Accurate and standard counterparts, Ripple's full score through the national tumor somatic mutation high-throughput

Today, the Rip Gene Harvesting Newsletter, Ripple Medical Laboratory conducted the "2018 National High-throughput Sequencing and Detection of Tumor Mutations in Tumors" by the Health and Medical Research Center.
Happy news! Accurate and standard counterparts, Ripple's full score through the national tumor somatic mutation high-throughput
Case Study|Rip detection found a rare mutation in EGFR to expand the EGFR-TKI mutation spectrum

Case Study|Rip detection found a rare mutation in EGFR to expand the EGFR-TKI mutation spectrum

EGFR mutation is one of the important mechanisms of non-small cell lung cancer (NSCLC). The NCCN guidelines clearly indicate that there is a significant correlation between EGFR mutation and patient sensitivity to tyrosine kinase inhibitors. It is strongly recommended to perform mutation detection during diagnosis and treatment. EGFR mutations mainly occur in exons 18-21, of which 19 exon deletion mutations and exon 21 L858R mutations account for more than 80% of all EGFR mutations, which are common pathogenic mutations.
Case Study|Rip detection found a rare mutation in EGFR to expand the EGFR-TKI mutation spectrum
请拖入内容到容器

Address: 21-23, Health Valley, No. 1500, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang, China

Copyright: Hangzhou Repugene Technology Co., Ltd.    Powered by www.300.cn 浙ICP备16003170号-1

CONTACT US

Let precision health care enter the public

APP download

WeChat

请拖入内容到容器